Bone is the most frequent site of metastasis in breast
cancer. This causes destructive osteolytic lesions. To achieve
metastasis to bone, breast cancer cells must proliferate in a
new microenvironment, arrest on extracellular matrix and
invade. Breast cancer cells progress in the invasive processes
only if they destroy bone with the assistance of osteoclasts. In
this work, we present data suggesting that MCF-7 cells, an
estradiol receptor–positive cell line that exhibits modest
invasive capacity, proliferate in the presence of soluble factors
secreted by the osteogenic cell line SaOS-2. The cells
acquire a more aggressive phenotype when cultured on an
extracellular matrix produced by the same osseous cell line.
Acquisition of the invasive phenotype appears to be related to
the capacity of bone extracellular matrix to induce the
expression of urokinase-like plasminogen activator by MCF-7
cells, which is specific for MCF-7 cells, given that MDA-231
cells, an estradiol receptor–negative and more aggressive cell
line, did not show significant changes when cultured in the
presence of soluble and insoluble bone factors.
en_US
Patrocinador
dc.description.sponsorship
This work was supported by grant 8970028 from Fondo de
Desarrollo de Ciencia y Tecnologia (FONDECYT, to JM) and by
FONDECYT 1980262 (to VC).